NASDAQ: SUPN · Health Care / Biotechnology: Pharmaceutical Preparations

Supernus Pharmaceuticals Inc.

How Supernus Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.4B

Price

$41.84

P/E

-55.6

EPS (TTM)

$-0.75

1-year return

-24.9%

Dividend yield

0.0%

52-week range

$37.88–$44.79

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources